S.02: Symposium: Long-term outcome of schizophrenia
|
|
|
S.02.01: Nancy Andreasen - USA
|
The Iowa Longitudinal Study: long-term outcomes in schizophrenia
|
|
|
|
S.02.02: Matti Isohanni - Finland
|
Midlife progression in brain tissue loss and clinical outcomes of schizophrenia in the Northern Finland 1966 Birth Cohort Study
|
|
|
-
|
S.02.04: Mark Weiser - Israel
|
Employment status in patients with schizophrenia and bipolar disorders
|
S.03: Symposium: News about 5-HT1A and depression
|
|
|
|
S.03.01: Pierre Blier - Canada
|
Role of the 5-HT1A receptors in the mechanism of action of antidepressant treatments
|
|
|
|
S.03.03: Hamish McAllister-Williams - United Kingdom
|
5-HT1A receptors in depressed patients: Evidence from PET, post mortem and EEG based studies
|
|
|
|
S.03.04: Kjell Fuxe - Sweden
|
FGFR1-5-HT1A receptor heterocomplexes: relevance for neuroplasticity and depression
|
S.04: Symposium: Trace amine-associated receptor 1 (TAAR1): from cell to clinic
|
|
|
|
S.04.01: David Grandy - USA
|
Discovery of the trace amine-associated receptor (TAAR)
|
|
|
|
S.04.02: Raul Gainetdinov - Italy
|
Molecular modulation of dopamine transmission by TAAR1
|
E.01: Educational update session: The roadmap for mental health research in Europe
|
|
|
|
E.01.01: Josep Maria Haro - Spain
|
ROAMER – collaborative effort to develop a mental health research roadmap: the process
|
|
|
|
E.01.02: Til Wykes - United Kingdom
|
ROAMER – collaborative effort to develop a mental health research roadmap: the results
|
